This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Drugs > Antithrombin alfa (ATryn) for pre-eclampsia in pre-term women

< Back

Antithrombin alfa (ATryn) for pre-eclampsia in pre-term women


Pregnancy and Childbirth

August 2016

Pre-eclampsia is a condition that affects some pregnant women during the second half of their pregnancy. Signs include high blood pressure and protein in the urine. Most cases are mild, but the condition can lead to serious complications for both mother and baby.
Antithrombin alfa is a new drug for the treatment of pre-eclampsia that is given straight into the blood by a drip. It is being studied to see whether it improves the symptoms of pre-eclampsia and if it is safe to use for pregnant women with this disease. If antithrombin alfa is licensed for use in the UK, it could provide a new treatment for pregnant women with pre-eclampsia.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

PDF Report


Connect to the Innovation Observatory


Load More Related Posts

Get Alerts